Results 181 to 190 of about 13,589 (222)

Endocrine Manipulation of Meningiomas with Medroxyprogesterone Acetate

Surgical Neurology, 1989
Medroxyprogesterone acetate (MPA) acted as a competitive binder to progesterone receptors (PR) of meningioma cytosols after in-vivo administration (PRmean =15.6 fmol/mg protein 338.3 fmol/g tumor, n = 15), in comparison to 54.9 fmol/mg protein (2813 fmol/g tumor) in our untreated meningioma series (n = 58).
Ernst R. Waelti, Thomas-Marc Markwalder
openaire   +1 more source

Treatment of alopecia X with medroxyprogesterone acetate

Veterinary Dermatology, 2013
BackgroundAlopecia X is a common cause of noninflammatory alopecia in Pomeranian dogs. In the past, treatment with growth hormone injections resulted in hair regrowth in many individuals. Progesterone can induce mammary‐derived growth hormone and is used to treat dogs with congenital growth hormone deficiency.Hypothesis/ObjectivesTo determine whether ...
Linda A, Frank, Jacqueline B, Watson
openaire   +2 more sources

Enzymatic assay of medroxyprogesterone acetate in plasma

Journal of Steroid Biochemistry, 1980
Abstract A method is described for the enzymatic assay of medroxyprogesterone acetate (MPA) in plasma. After extraction and chromatographic purification of the steroid it is desacetylated and rechromatographed on the same Lipidex column. The primary enzymatic reaction is carried out with 3α,20β-hydroxy-steroid dehydrogenase and the NAD + formed is ...
H, Adlercreutz, M, Härkönen
openaire   +2 more sources

The metabolic fate of medroxyprogesterone acetate in the baboon

Journal of Steroid Biochemistry, 1976
Abstract The metabolic fate of medroxyprogesterone acetate (6α-methyl-17α-acetoxyprogesterone, MAP) was studied in intact baboons and in those with bile fistulas. The steroid moiety was labeled with 3 H at positions 1 and 2 and the 17α-acetate with 14 C, thus affording the opportunity to ascertain the loss of the 17-acetoxy group and the fate of ...
M, Ishihara, Y, Kirdani, Y, Osawa, A A, Sandberg   +3 more
openaire   +2 more sources

Treatment of seizures with medroxyprogesterone acetate

Neurology, 1984
Medroxyprogesterone acetate (MPA), a synthetic progesterone, was added to the antiepileptic drug regimen of 14 women who had uncontrolled seizures. Of the 11 women who developed amenorrhea, 7 reported fewer seizures during MPA therapy. Overall reductions in seizure frequency averaged 30% (n = 11), declining from a baseline 8.3 +/- 5.8 seizures per ...
R H, Mattson, J A, Cramer, B V, Caldwell, B C, Siconolfi   +3 more
openaire   +2 more sources

Effect of Medroxyprogesterone Acetate on Peritoneal Adhesion

Asia-Oceania Journal of Obstetrics and Gynaecology, 1988
AbstractSixteen albino female non‐pregnant rabbits of the blanc du Bouscat strain are the material of this study. Ten animals received a single intramuscular injection of 20 mg medroxyprogesterone acetate (MPA). The other six received placebo (normal saline).
S A, Nayel, M A, el Habashy, N E, Banna, S A, Sehrawy   +3 more
openaire   +2 more sources

MANAGEMENT OF ENDOMETRIOSIS WITH ORAL MEDROXYPROGESTERONE ACETATE

Obstetrical & Gynecological Survey, 1976
Efficacy of oral medroxyprogesterone acetate (MPA) was assessed in 35 women with an established diagnosis of endometriosis (33 pelvic and 2 abdominal). MPA was given in a dosage of 30 mg daily for 90 days. Results indicated improvement or remission in all cases, even though breakthrough bleeding occurred in 8.
K S, Moghissi, C R, Boyce
openaire   +2 more sources

The Cushing Syndrome Induced by Medroxyprogesterone Acetate

Annals of Internal Medicine, 1989
Excerpt The Cushing syndrome is a constellation of abnormalities resulting from chronic excess glucocorticoid activity (1).
K, Siminoski, P, Goss, D J, Drucker
openaire   +2 more sources

UNSUCCESSFUL TREATMENT OF ACROMEGALY WITH MEDROXYPROGESTERONE ACETATE

Acta Endocrinologica, 1974
ABSTRACT Six patients with active acromegaly were treated with medroxyprogesterone acetate (MPA) in a dose of 10 mg four times a day for periods of two weeks to six months. Basal growth hormone (GH) levels, oral glucose tolerance tests, insulin tolerance tests, and arginine stimulation tests were obtained before and after one week, one month ...
R L, Atkinson, R C, Dimond, W J, Howard, J M, Earll   +3 more
openaire   +2 more sources

The Effect of Medroxyprogesterone Acetate on Blood Pressure

International Journal of Gynecology & Obstetrics, 1979
ABSTRACTTwenty‐four women (21 normotensive and 3 hypertensive) aged 16–35 years received 150‐mg injections of medroxyprogesterone acetate (MPA) for contraception. Their blood pressure (BP) was measured under basal conditions by the same nurse before treatment and at 1‐, 2‐ and 3‐month intervals. Their mean BP fell from 124.1/79.4 to 119.8/74.6 mm Hg at
H R, Black, P, Leppert, A, DeCherney
openaire   +2 more sources